• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

随着治疗时间的推移,环孢素的最佳血药浓度会下降。

Optimal cyclosporine plasma levels decline with time of therapy.

作者信息

Klintmalm G, Säwe J, von Bahr C, Ringdén O, Lundgren G, Wilczek H, Tydén G, Groth C G

出版信息

Transplant Proc. 1984 Oct;16(5):1208-11.

PMID:6385380
Abstract

To avoid nephrotoxicity and hepatotoxicity the CsA-PL should be kept at less than 500 ng/mL during the first month after transplantation and less than 200 ng/mL after four months. After ten months most patients in this study had a CsA-PL of less than 150 ng/mL and many had levels of less than 50 ng/mL with an apparently good immunosuppressive effect. Rejections showed no correlation with high or low CsA-PL. Continuous monitoring of CsA-PL is recommended for the management of renal allograft recipients.

摘要

为避免肾毒性和肝毒性,移植后第一个月环孢素A-磷脂(CsA-PL)应保持在500 ng/mL以下,四个月后应保持在200 ng/mL以下。十个月后,本研究中的大多数患者CsA-PL低于150 ng/mL,许多患者的水平低于50 ng/mL,且免疫抑制效果明显良好。排斥反应与CsA-PL的高低无关。建议对肾移植受者进行CsA-PL的持续监测。

相似文献

1
Optimal cyclosporine plasma levels decline with time of therapy.随着治疗时间的推移,环孢素的最佳血药浓度会下降。
Transplant Proc. 1984 Oct;16(5):1208-11.
2
Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection.肾移植患者的环孢素血药浓度。与肾毒性和移植肾排斥反应的关系。
Transplantation. 1985 Feb;39(2):132-7. doi: 10.1097/00007890-198502000-00005.
3
Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation.
Pharmacotherapy. 1998 Mar-Apr;18(2):282-7.
4
A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.肾移植后环孢素浓度与其治疗效果及毒性关系的前瞻性研究。
Br J Clin Pharmacol. 1990 Sep;30(3):443-52. doi: 10.1111/j.1365-2125.1990.tb03796.x.
5
Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?肾移植受者监测血浆环孢素是否存在治疗范围?
Nephrol Dial Transplant. 1988;3(6):814-9.
6
Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
Transplant Proc. 1986 Apr;18(2 Suppl 1):82-91.
7
The impact of steady-state cyclosporine concentrations on renal allograft outcome.稳态环孢素浓度对肾移植结局的影响。
Transplantation. 1990 Jan;49(1):30-4. doi: 10.1097/00007890-199001000-00007.
8
Cyclosporine in the treatment of acute allograft rejection refractory to high-dose methylprednisolone: results of a prospectively randomized trial.环孢素治疗对大剂量甲泼尼龙难治的急性移植排斥反应:一项前瞻性随机试验的结果
Transplant Proc. 1984 Oct;16(5):1202-4.
9
Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation.
Transplantation. 1988 Jan;45(1):86-90.
10
Two immunosuppressive drug regimens after renal transplantation: low dosage of cyclosporine adjusted on the basis of high-performance liquid chromatography whole blood levels and prednisone.
Transplant Proc. 1988 Feb;20(1 Suppl 1):401-5.